Parallax Volatility Advisers
AKCA

Parallax Volatility Advisers’s Akcea Therapeutics Inc AKCA Stock Holding History

Parallax Volatility Advisers’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,646
Closed -$75K – 4126
2019
Q1 		$75K Sell
2,646
-28,336
-91% -$825K ﹤0.01% 2183
2018
Q4 		$934K Buy
30,982
+12,218
+65% +$342K ﹤0.01% 1341
2018
Q3 		$657K Buy
+18,764
New +$568K ﹤0.01% 1374
2018
Q2 		– Sell
-326
Closed -$8K – 3698
2018
Q1 		$8K Sell
326
-1,942
-86% -$41.8K ﹤0.01% 1892
2017
Q4 		$39K Buy
+2,268
New +$44.5K ﹤0.01% 3356

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Parallax Volatility Advisers's AKCA Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Akcea Therapeutics Inc (AKCA) in Q2 2019, closing a stake of 2,646 shares — an estimated $75K sold.

Parallax Volatility Advisers first reported a position in AKCA in Q4 2017 and held it in 5 quarters. The position peaked at $934K in Q4 2018. 68 funds tracked by Wall St. Rank hold AKCA as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining Akcea Therapeutics Inc position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,646 Akcea Therapeutics Inc shares in Q2 2019, an estimated $75K.
  • Parallax Volatility Advisers first reported a position in Akcea Therapeutics Inc in Q4 2017 and held it in 5 quarters.
  • Parallax Volatility Advisers's Akcea Therapeutics Inc position peaked at $934K in Q4 2018.
  • 68 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.